| Cat. No. | Product Name | Information | 
            
                
            	| PC-23849 | SMEPPI NF-κB p65 inhibitor | SMEPPI is a small molecule inhibitor of expression and activation of NF-κB p65, induces NF-κB p65 proteasomal degradation and has anti-diabetic and anti-inflammatory activities. | 
            
                
            	| PC-22689 | ZM600 HSCs activation inhibitor | ZM600 is a novel antihepatic fibrosis compound that shows significant inhibitory effect on the activation of hepatic stellate cells (HSCs), specifically inhibits the activation of NF-κB, PI-3K/AKT, and TGF-β/Smads signaling pathways. | 
            
                
            	| PC-21657 | CSB-0914 NF-κB inhibitor | CSB-0914 is a small molecule NF-κB inhibitor that stably binds to NF-κB-p50 subunit, exhibits significant efficacy in reducing basophil activation assay induced by FcεRI receptors with IC50 of 98.4 nM. | 
            
                
            	| PC-21362 | AE-848 NF-κB modualator | AE-848 is a small molecule modulator of NF-κB and PI3K/AKT/mTOR signaling pathways, shows potent in vitro and in vivo anti-myeloma activity. | 
            
                
            	| PC-20991 | EVP4593 nSOC inhibitor | EVP4593 (EVP-4593) is an inhibitor of PMA/PHA-induced NF-κB pathway activation with IC50 of 9 nM, inhibits storeoperated calcium (Ca2+) entry (SOC) pathway in huntington's disease (HD) neurons. | 
            
                
            	| PC-45990 | (R)-(-)-Ibuprofen | An enantiomer of Ibuprofen that is generally not considered a COX inhibitor and is instead thought to be involved in pathways of lipid metabolism as it is incorporated into triglycerides along with fatty acids. |